Minimal-Dose Resistance Training for Improving sIgA and Cortisol (sIgA)

May 16, 2022 updated by: Luis Berlanga, Universidad Francisco de Vitoria

Minimal-Dose Resistance Training for Improving sIgA and Cortisol Among Young, Health and Sedentary People

Whereas the role of endurance training on immune function has been widely studied, little is known about the role of resistance training (RT). In this cross-over randomized controlled study, it will be analysed the effects of three RT protocols which only differs in volume in improving secretory immunoglobulin A (sIgA) and cortisol in saliva among young, health and sedentary people

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
    • Madrid
      • Pozuelo De Alarcón, Madrid, Spain, 28223
        • Universidad Francisco de Vitoria

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 28 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18-30 years
  • Sedentary

Exclusion Criteria:

  • to have had COVID-19 during the last 3 months
  • to have been vaccinated against COVID-19 during the last 3 months
  • physical limitations or health problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Resistance exercise for 10 min
Resistance circuit training of 10 min
Behavioral: Resistance training
Resistance circuit training
Experimental: Resistance exercise for 20 min
Resistance circuit training of 20 min
Behavioral: Resistance training
Resistance circuit training
Experimental: Resistance exercise for 30 min
Resistance circuit training of 30 min
Behavioral: Resistance training
Resistance circuit training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Concentration of secretory immunoglobulin A (sIgA)
Time Frame: 2 weeks
Secretory Immunoglobulin A in saliva
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Concentration of salivary cortisol (Scortisol)
Time Frame: 2 weeks
Cortisol in saliva
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Francisco de Vitoria

Investigators

  • Principal Investigator: Luis Berlanga, Universidad Francisco de Vitoria

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Actual)

February 24, 2022

Study Completion (Actual)

March 24, 2022

Study Registration Dates

First Submitted

February 2, 2022

First Submitted That Met QC Criteria

February 2, 2022

First Posted (Actual)

February 3, 2022

Study Record Updates

Last Update Posted (Actual)

May 17, 2022

Last Update Submitted That Met QC Criteria

May 16, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • UFV2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resistance Training

Clinical Trials on Resistance training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe